-
Canara Robeco IPO opens on October 9 with a price band of ₹253–₹266 per share and a 13% GMP premium.
-
Rubicon Research IPO also opens on October 9, offering a 16% grey market premium before listing.
-
Canara HSBC Life Insurance IPO to open on October 10, with shares trading at a 9% premium in the grey market.
Canara Robeco IPO Gains Momentum in Grey Market
The Canara Robeco IPO is attracting strong investor attention before its official launch. The asset management company has set a price band between ₹253 and ₹266 per share for its upcoming ₹1,326-crore public issue. The subscription window will be open from October 9 to October 13, while the anchor book opens a day earlier on October 8.
According to market trackers at Investorgain, the Canara Robeco IPO is currently trading at a grey market premium (GMP) of ₹35. This indicates that the stock could list at a 13.16% gain over its issue price when it debuts on the stock exchanges. The GMP trend reflects growing investor optimism about the company’s performance and its long-standing reputation in the mutual fund and asset management space.
The Canara Robeco IPO is being seen as one of the most anticipated offerings of October 2025, as it brings a trusted financial brand with a solid track record in fund management to the capital markets. Analysts believe that the company’s consistent growth, stable profitability, and the recent surge in mutual fund investments in India are supporting strong investor sentiment ahead of the issue.
Rubicon Research IPO Commands Strong 16% Grey Market Premium
The Rubicon Research IPO is another major offering that will open for subscription on October 9, 2025, alongside the Canara Robeco issue. The pharmaceutical company, headquartered in Mumbai, has fixed a price band of ₹461–₹485 per share for its ₹1,377.5-crore IPO.
As per data from Investorgain, the Rubicon Research IPO is enjoying a grey market premium of ₹80 per share, translating to a potential 16.49% listing gain. Such a strong response indicates investor confidence in the pharmaceutical sector’s continued growth and Rubicon’s ability to deliver on expansion and innovation goals.
The Rubicon Research IPO will use the net proceeds from the fresh issue for repayment of certain loans, funding acquisitions, supporting strategic growth initiatives, and general corporate purposes. The company plans to strengthen its global presence through inorganic growth and increase its product pipeline across multiple therapeutic areas.
Analysts point out that Rubicon Research’s financial health, focus on R&D, and diversified business model make it a promising bet for long-term investors. The growing optimism in the grey market suggests strong listing prospects once the shares are officially listed.
Canara HSBC Life Insurance IPO Joins the Line-Up
Following the excitement around the Canara Robeco IPO and Rubicon Research IPO, the Canara HSBC Life Insurance IPO is also gaining strong traction among investors. The insurer has set its price band between ₹100 and ₹106 per share for its ₹2,516-crore public issue.
At the upper end of the price band, the company will be valued at around ₹10,000 crore. The IPO will open for subscription from October 10 to October 14, with its anchor book opening on October 9.
In the grey market, Canara HSBC Life shares are trading at a premium of around 9%, signaling positive investor expectations. The company’s long-standing brand strength, backed by Canara Bank and HSBC, along with a growing customer base in the insurance sector, is expected to drive demand during the IPO period.
Experts say that the life insurance segment in India continues to expand rapidly due to increasing awareness about financial protection and tax benefits, which could benefit the company in the long term.
Grey Market Sentiment Signals Strong IPO Season
With the Canara Robeco IPO, Rubicon Research IPO, and Canara HSBC Life Insurance IPO all showing strong premiums in the unregulated grey market, the sentiment among investors appears bullish. Grey market premiums (GMPs) often act as an early indicator of how IPOs might perform upon listing, though actual results depend on final subscription levels and market conditions.
The grey market activity for these three upcoming IPOs shows growing investor confidence in both the financial services and pharmaceutical sectors. With Indian stock markets maintaining a positive tone and retail investors actively participating in new issues, these IPOs could see significant demand during the subscription period.
Analysts advise investors to carefully review each company’s fundamentals and financial performance before subscribing, but they agree that the current GMP trends reflect optimism and strong listing potential across all three offerings.
Conclusion
The October IPO season is heating up with three major public issues — Canara Robeco IPO, Canara HSBC Life Insurance IPO, and Rubicon Research IPO — each showing strong grey market activity. While Canara Robeco leads the financial sector entries with a 13% expected listing gain, Rubicon Research tops the GMP chart with a 16% premium, followed by Canara HSBC Life at 9%.
Overall, the growing excitement in the grey market suggests that investors are keen to participate in high-quality companies with strong fundamentals, potentially setting the stage for another round of successful listings on the Indian bourses.
